共 85 条
[1]
Pazianas M(2011)Osteonecrosis of the jaw and the role of macrophages J Natl Cancer Inst 103 232-240
[2]
Mehrotra B(2009)Bisphosphonates—role in cancer therapies J Oral Maxillofac Surg 67 19-26
[3]
Dunford JE(2008)Structure–activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase J Med Chem 51 2187-2195
[4]
Kwaasi AA(2010)Bisphosphonate-related osteonecrosis of the jaw combined with jaw metastasis of prostate adenocarcinoma: report of a case J Oral Maxillofac Surg 68 863-867
[5]
Rogers MJ(2003)Zoledronic acid induces significant and long-lasting modifications of circulating angiogenic factors in cancer patients, and by “in vitro” research Clin Cancer Res 9 2893-2897
[6]
Frei M(2002)Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats Cancer Res 62 6538-6544
[7]
Bornstein MM(2006)Osteonecrosis of the jaws in patients treated with bisphosphonates-histomorphologic analysis in comparison with infected osteoradionecrosis J Oral Pathol Med 35 155-160
[8]
Schaller B(2005)Bisphosphonate osteochemonecrosis (bis-phossy jaw): is this phossy jaw of the 21st century? J Oral Maxillofac Surg 63 682-689
[9]
Santini D(2009)Osteonecrosis of the jaw: who gets it, and why? Bone 44 4-10
[10]
Vincenzi B(2012)Bisphosphonates modulate the expression of OPG and M-CSF in hMSC-derived osteoblasts Clin Oral Investig 16 1153-1159